Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer [Phase 1]
A Phase 1 trial is evaluating a mutant KRAS-targeted long peptide vaccine for people at high risk of developing pancreatic cancer, and the s…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating neoadjuvant/adjuvant GVAX versus mKRASvax given with anti-PD-1 and anti-CD137 in surgically resecta…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer [Phase 1]
Phase 1 trial update of a pooled mutant KRAS-targeted long peptide vaccine combined with nivolumab and ipilimumab in patients with resected …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Holistic Acupuncture for Patients With Chemotherapy Induced Nausea [NA]
A clinical trial update for a holistic acupuncture intervention to treat chemotherapy-induced nausea, sponsored by Vejle Hospital, currently…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations [Phase 2, Phase 3]
The DETERMINE trial update investigates the combination of Trastuzumab and Pertuzumab for HER2-amplified or activating-mutant cancers in adu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating carbon ion radiotherapy for frail patients with pancreatic cancer, sponsored by Yonsei University, current…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer [NA]
This clinical trial update notes a study evaluating Alpha Tau Medical's Alpha DaRT alpha radiation emitter device for locally advanced pancr…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
This document reports a clinical trial update on a blood-based biomarker study for pancreatic adenocarcinoma that is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: REVOLUTION Surgery (REVOLUTION Surgery)
The REVOLUTION Surgery trial, led by the University of Edinburgh, is currently recruiting and studying cachexia alongside multiple cancers i…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate [Phase 2]
A Phase 2 clinical trial is evaluating pancreatic parenchymal injection of N-butyl-2-cyanoacrylate for issues related to pancreaticoduodenec…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer [NA]
Clinical trial update on the prognostic outcomes of total mesopancreas excision for pancreatic head cancer; the study is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer [NA]
Clinical trial update indicates Alpha Tau Medical's alpha radiation emitter device is being studied for advanced pancreatic cancer and is cu…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. [Phase 1]
Phase 1 trial update of Naptumomab Estafenatox in combination with durvalumab in selected advanced or metastatic solid tumors, including eso…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer [NA]
A completed clinical trial evaluating how surgical resection influences circulating tumor DNA in patients with resectable pancreatic cancer.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer [Phase 1]
This is a Phase 1 clinical trial update for a combination of calaspargase pegol-mnkl and cobimetinib in locally advanced or metastatic pancr…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer [Phase 1]
Phase 1 study of NMK89, a 89Zr-labeled hNd2 radiotracer, evaluating safety, tolerability, pharmacokinetics, radiation dosimetry, and PET ima…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
This completed clinical trial evaluates portal vein stenting for malignant obstruction, reporting on feasibility and safety and detailing ob…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma [NA]
Update on an ongoing study evaluating gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban in advanced pancreatic ductal adenocarcinoma; th…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
A clinical trial update notes ongoing recruitment at Herlev Hospital to study how the gut microbiota influences pancreatic cancer and its pr…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study of iExosomes in KRAS G12D-mutant metastatic pancreatic cancer, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers [Phase 1]
Phase 1 clinical trial evaluating hypofractionated radiotherapy in combination with durvalumab (MEDI4736) and tremelimumab in patients with …
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy [NA]
This clinical trial update describes PROACTIVE, a study assessing surgical resection outcomes after neoadjuvant chemotherapy in locally adva…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
This clinical trial update describes evaluating a mixed meal test to diagnose and characterize diabetes mellitus type 3c associated with pan…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
Clinical trial update on adding paricalcitol to chemotherapy for previously untreated metastatic pancreatic ductal adenocarcinoma; the Phase…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy
This clinical trial update reports on evaluating an early radiomic signature in patients with metastatic pancreatic adenocarcinoma treated w…